Aster DM Healthcare (ASTERDM) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
18 Jun, 2026Market opportunity and industry trends
India's healthcare delivery market is projected to exceed $100 billion by FY26, driven by a vast population, low hospital bed density, and rising healthcare expenditure.
Out-of-pocket expenses remain high, but health insurance coverage is expected to expand to 46% by FY25.
Medical tourism and an aging population are significant growth drivers, with medical tourists projected to reach ~3 million by 2030.
Business overview and operational footprint
Operates 19 hospitals, 13 clinics, 215 pharmacies, and 232 labs/PECS across 15 cities in 5 states, with 4,867 capacity beds and 68% occupancy in FY24.
Holds the second-largest hospital network in South India, leading in Kerala and strong positions in Karnataka, Maharashtra, Andhra Pradesh, and Telangana.
Revenue mix is diversified across geographies and specialties, with 58% from niche specialties and increasing contributions from medical value travel and insurance.
Financial performance and growth
Revenue grew at a 23% CAGR over five years, reaching INR 3,699 crore in FY24; operating EBITDA margin expanded to 17%.
Adjusted PAT rose 63% YoY to INR 240 crore in FY24, with ROCE improving to 16.4%.
Mature hospitals delivered 22.4% EBITDA margin and 32% ROCE in FY24.
Net debt/EBITDA (pre-IndAS) improved to 1.1x.
Latest events from Aster DM Healthcare
- Record net profit and EPS in Q1 FY25, driven by GCC business sale and strong India growth.ASTERDM
Q1 24/259 Jul 2026 - Double-digit revenue and profit growth, margin expansion, and strong outlook in H1 FY25.ASTERDM
Q2 24/258 Jul 2026 - Q2 FY26 delivered strong growth, margin expansion, hospital launches, and QCL merger progress.ASTERDM
Q2 25/268 Jul 2026 - Merger forms a top-three Indian hospital chain with 10,150+ beds, strong synergies, and Blackstone backing.ASTERDM
M&A Announcement8 Jul 2026 - 15% YoY revenue and 22% EBITDA growth, merger progress, and internal restructuring marked Q3FY26.ASTERDM
Q3 25/268 Jul 2026 - FY25 revenue up 12%, EBITDA margin at 19.5%, QCIL merger and major one-time gains boost results.ASTERDM
Q4 24/258 Jul 2026 - Aster DM and QCIL merge to form a top 3 Indian hospital chain with 10,150+ beds and strong growth.ASTERDM
Investor Presentation18 Jun 2026 - Merger with QCIL positions the group among India's top 3 hospital chains by scale and revenue.ASTERDM
Investor presentation3 Jun 2026 - Robust revenue and EBITDA growth, with the Quality Care merger and expansion fueling future gains.ASTERDM
Q4 25/261 May 2026